SYNHUnknown
Syneos Health, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Syneos Health, Inc. (SYNH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are SYNH insiders buying or selling?
Syneos Health, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 123 Form 4 filings for SYNH: 5 buys ($873.5K) and 118 sells ($17.9B).
Source: SEC EDGAR Form 4
Key Statistics (January 2018 – Jul 29, 2022)
Total Form 4 filings
123
SEC EDGAR
Insider filers
16
Insider buys (5)
$873.5K
Insider sells (118)
$17.9B
Insider sentiment
Net sellingNet insider flow of $17.9B in net selling since January 2018.
Recent SYNH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Michael Lee Brooks | Chief Operating Officer | Sale | 1.5K | $78.00 | $117.2K | SEC ↗ |
| Jul 22, 2022 | Michael Lee Brooks | Chief Operating Officer | Sale | 1.5K | $76.00 | $114.2K | SEC ↗ |
| Jul 21, 2022 | Jonathan Olefson | General Counsel & Corp Secty | Sale | 2.2K | $75.00 | $166.1K | SEC ↗ |
| Jul 20, 2022 | Michael Lee Brooks | Chief Operating Officer | Sale | 1.5K | $74.00 | $111.1K | SEC ↗ |
| Jul 20, 2022 | Michelle Keefe | Chief Executive Officer | Sale | 8.3K | $72.81 | $606.7K | SEC ↗ |
| Jul 20, 2022 | Jason M. Meggs | Chief Financial Officer | Sale | 7.5K | $72.81 | $546.1K | SEC ↗ |
| Jul 11, 2022 | Donna Hildebrand Kralowetz | EVP, Chief Accounting Officer | Sale | 1.1K | $73.16 | $84.1K | SEC ↗ |
| Jun 2, 2022 | Matthew E. Monaghan | Director | Sale | 200 | $74.35 | $14.9K | SEC ↗ |
| Feb 2, 2022 | Donna Hildebrand Kralowetz | SVP, Chief Accounting Officer | Sale | 1.1K | $90.00 | $95.0K | SEC ↗ |
| Jan 3, 2022 | Michael Lee Brooks | Chief Development Officer, Clinical Solutions | Sale | 93 | $103.00 | $9.6K | SEC ↗ |
| Dec 27, 2021 | Jonathan Olefson | General Counsel & Corp Secty | Sale | 1.9K | $100.95 | $190.7K | SEC ↗ |
| Dec 23, 2021 | Michael Lee Brooks | Chief Development Officer, Clinical Solutions | Sale | 93 | $99.00 | $9.2K | SEC ↗ |
| Dec 21, 2021 | Linda S Harty | Director | Sale | 4.1K | $97.02 | $399.9K | SEC ↗ |
| Sep 8, 2021 | Donna Hildebrand Kralowetz | SVP, Chief Accounting Officer | Sale | 248 | $94.30 | $23.4K | SEC ↗ |
| Sep 3, 2021 | Jason M. Meggs | Chief Financial Officer | Sale | 9.2K | $95.00 | $876.2K | SEC ↗ |
| Aug 4, 2021 | Alistair Macdonald | Chief Executive Officer | Sale | 40.3K | $88.19 | $3.6M | SEC ↗ |
| Jul 19, 2021 | Matthew E. Monaghan | Director | Sale | 170 | $88.64 | $15.1K | SEC ↗ |
| Jul 7, 2021 | Jason M. Meggs | Chief Financial Officer | Sale | 660 | $90.00 | $59.4K | SEC ↗ |
| Jul 2, 2021 | Jason M. Meggs | Chief Financial Officer | Sale | 4.7K | $90.00 | $420.1K | SEC ↗ |
| Jun 21, 2021 | Donna Hildebrand Kralowetz | SVP, Chief Accounting Officer | Sale | 590 | $85.03 | $50.2K | SEC ↗ |
| Jun 9, 2021 | John L. Maldonado | Director | Sale | 6.3M | $81.20 | $512.2M | SEC ↗ |
| Jun 9, 2021 | Tom Allen | Director | Sale | 6.3M | $81.20 | $512.2M | SEC ↗ |
| Jun 9, 2021 | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sale | 6.3M | $81.20 | $512.2M | SEC ↗ |
| Jun 9, 2021 | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sale | 6.3M | $81.20 | $512.2M | SEC ↗ |
| Jun 9, 2021 | ADVENT INTERNATIONAL CORP/MA | 10% Owner | Sale | 6.3M | $81.20 | $512.2M | SEC ↗ |
Showing the 25 most recent of 123 Form 4 filings for Syneos Health, Inc..
Most active SYNH insiders
- ADVENT INTERNATIONAL CORP/MA42 filings
- THOMAS H. LEE ADVISORS, LLC16 filings
- Alistair Macdonald11 filings
- Jason M. Meggs10 filings
- Michelle Keefe7 filings
Ask anything about SYNH insider activity
Use Trabud's AI agent to query Syneos Health, Inc.'s Form 4 history in plain English — "Show me SYNH CEO purchases this year" or compare it against any other ticker.
Open the AI agentSYNH insider trading FAQ
Are Syneos Health, Inc. insiders buying or selling?
Syneos Health, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2018, Trabud has recorded 123 Form 4 filings for SYNH: 5 buys ($873.5K) and 118 sells ($17.9B). Over the full record that is net selling of $17.9B.
How many insiders trade SYNH stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Syneos Health, Inc.. The most recent filing was accepted on Jul 29, 2022.
Where does Trabud get SYNH insider trading data?
All SYNH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.